AcandiS Stenting of Intracranial STENosis - regisTry (ASSISTENT)
Sponsor: Acandis GmbH
Listed as NCT03902444, this observational or N/A phase trial focuses on Intracranial Stenosis and remains ongoing. Sponsored by Acandis GmbH, it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Dec 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2025 — Dec 2025 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Sep 2021 — Mar 2023 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Sep 2020 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
-
Jun 2019 — Oct 2019 [monthly]
Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Acandis GmbH
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bochum, Germany , Cologne, Germany , Düsseldorf, Germany , Essen, Germany , Göttingen, Germany , Hamburg, Germany , Heidelberg, Germany , Homburg, Germany , Ingolstadt, Germany , Magdeburg, Germany and 5 more locations